Your browser doesn't support javascript.
loading
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy.
Liu, Zaoqu; Shi, Meixin; Ren, Yuqing; Xu, Hui; Weng, Siyuan; Ning, Wenjing; Ge, Xiaoyong; Liu, Long; Guo, Chunguang; Duo, Mengjie; Li, Lifeng; Li, Jing; Han, Xinwei.
Afiliación
  • Liu Z; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Shi M; Interventional Institute of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Ren Y; Interventional Treatment and Clinical Research Center of Henan Province, Zhengzhou, 450052, Henan, China.
  • Xu H; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Weng S; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Ning W; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Ge X; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Liu L; Department of Emergency Center, Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China.
  • Guo C; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Duo M; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Li L; Department of Endovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Li J; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Han X; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Mol Cancer ; 22(1): 35, 2023 02 16.
Article en En | MEDLINE | ID: mdl-36797756
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistemas CRISPR-Cas / Neoplasias Límite: Humans Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistemas CRISPR-Cas / Neoplasias Límite: Humans Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China